William Mohlenbrock, MD, founder and CMO of Verras and a practicing orthopedic surgeon at Scripps Memorial Hospital in La Jolla, Calif., discussed physician variation in a recent webinar presented by ...
This article is sponsored by WellSky. As long-term care providers face tighter staffing, heavier documentation loads, and ...
On this episode of Ropes & Gray’s podcast series Non-binding Guidance, health care partner David Peloquin and life sciences regulatory and compliance counsel Sarah Blankstein discuss the FDA's recent ...
Positioned to advance four clinical programs through multiple upcoming milestones “We acknowledge today the extraordinary contributions and productivity of our discovery team, who have enabled the ...
Nuwellis, Inc. has announced the termination of its REVERSE-HF clinical trial, which was evaluating the use of ultrafiltration versus IV loop diuretics for managing fluid in heart failure patients.
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results